Skye Bioscience (SKYE) Assets (2012 - 2026)
Skye Bioscience (SKYE) recorded Assets of $11.03 million in Q2 2026, down 78.8% from $52.16 million a year earlier and down 43.2% from the prior quarter.
Skye Bioscience (SKYE) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience reported Assets of $28.31 million, down 61.1% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 60.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $72.76 million in FY2024 (+509.4%), $11.94 million in FY2023 (+31.1%), $9.11 million in FY2022 (-7.5%) and $9.86 million in FY2021 (+268.9%).
- The Q2 2026 figure is the lowest quarterly Assets since Q2 2023.
- On a year-over-year basis, Assets has declined for six consecutive quarters, with growth averaging 75.1% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 509.4% in Q4 2024, against a decline of 78.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $19.42 million (Q1 2026), $28.31 million (Q4 2025) and $41.32 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Skye Bioscience | 5.38 Mn | -52.34 Mn | - | 5.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.07 Mn |
| Jun 30, 2026 | 11.03 Mn |
| Mar 31, 2026 | 19.42 Mn |
| Dec 31, 2025 | 28.31 Mn |
| Sep 30, 2025 | 41.32 Mn |
| Jun 30, 2025 | 52.16 Mn |
| Mar 31, 2025 | 64.79 Mn |
| Dec 31, 2024 | 72.76 Mn |
| Sep 30, 2024 | 81.54 Mn |
| Jun 30, 2024 | 87.26 Mn |
| Mar 31, 2024 | 94.84 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Sep 30, 2023 | 15.60 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 7.21 Mn |
| Dec 31, 2021 | 9.86 Mn |
Skye Bioscience Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();